Generactor,

We don't know. You are saying the maybe the power of the trial was not good enough ???. Again, don't know with the information provided. These were the numbers of patients approved by FDA. And yes, more patients will yield better power and better statistics.

But we know that:

Quote:

---

The incidence, frequency, and severity of adverse events (AEs) and serious adverse events (SAEs) were lower in the leronlimab group compared to the placebo group. Patients treated with placebo were more than twice as likely to experience SAEs or AEs compared to patients treated with leronlimab.

---

Quote:

---

At Day 3, more subjects treated with leronlimab reported improvement in total clinical symptom score compared to the placebo group (90% on leronlimab arm vs. 71% on placebo).

---

Quote:

---

In all treated patients, at the End of Treatment (or Day 14), patients in the leronlimab group were more than twice as likely to experience a beneficial improvement in scores compared to patients in the placebo group (50% vs 20%)

---

My point is: The USA alone (a COVID joke worldwide) is losing more than 1000 of our citizens PER DAY.

No drugs approved for Mild-Moderate infections with COVID.

There is a SAFE drug that has proven to help in a double-blinded trial and with several anecdotal results apart from a strong academic substantiation of MOA..

And “Nero fiddles while Rome burns” ...